Literature DB >> 2422969

Further studies on the antigenic diversity of the circumsporozoite proteins of the Plasmodium cynomolgi complex.

A H Cochrane, R W Gwadz, J W Barnwell, K K Kamboj, R S Nussenzweig.   

Abstract

The circumsporozoite (CS) proteins of strains of the Plasmodium cynomolgi complex have been examined using antisporozoite monoclonal antibodies (Mab) in various immunologic assays. We found extensive antigenic diversity in the repeating immunodominant epitope of the CS proteins of the various strains. Based on the antigenicity and the electrophoretic mobility of their CS protein, the 11 strains that we examined can be placed in 7 distinct groups. Our data also indicate homology between the immunodominant repetitive epitopes of the CS proteins of the Berok strain of P. cynomolgi and the human malaria parasite P. vivax.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422969     DOI: 10.4269/ajtmh.1986.35.479

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  4 in total

1.  Isolation of three distinct parasite populations expressing different circumsporozoite proteins from the Philippine strain of Plasmodium knowlesi.

Authors:  A H Cochrane; R W Gwadz; K K Kamboj
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

2.  Circumsporozoite protein of the human malaria parasite Plasmodium ovale identified with monoclonal antibodies.

Authors:  P M Procell; W E Collins; G H Campbell
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

3.  Use of non-human primate hepatocytes for in vitro study of the pre-erythrocytic stages of malaria parasites.

Authors:  P Millet; W E Collins; M Aikawa; A H Cochrane; P Nguyen-Dinh
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

4.  Stage-specific and species-specific antigens of Plasmodium vivax and Plasmodium ovale defined by monoclonal antibodies.

Authors:  P M Andrysiak; W E Collins; G H Campbell
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.